← Back to headlines
Eli Lilly's Incretin Portfolio Drives Continued Gains
Eli Lilly and Company (LLY) has seen continued financial gains, largely attributed to the strong performance of its incretin portfolio.
30 Mar, 13:31 — 30 Mar, 13:31
Sources
Showing 1 of 1 sources
Related Stories
Pathologist Shares Four Simple Rules for Weight Loss
24m ago
British Actress Nikki Sanderson Reveals Abuse Over Pregnancy in Her Forties
28m ago
Study Suggests Syphilis-Like Disease Spread in Ancient Vietnam, Challenging Columbus Theory
33m ago
Azerbaijani Sailor Evacuated from Ship in Constanța Port Due to Medical Emergency
34m ago